Psychiatric Side Effects Of Prescription And Over The Counter Medications PDF Download

Are you looking for read ebook online? Search for your book and save it on your Kindle device, PC, phones or tablets. Download Psychiatric Side Effects Of Prescription And Over The Counter Medications PDF full book. Access full book title Psychiatric Side Effects Of Prescription And Over The Counter Medications.

Psychiatric Side Effects of Prescription and Over-the-counter Medications

Psychiatric Side Effects of Prescription and Over-the-counter Medications
Author: Thomas Markham Brown
Publisher: American Psychiatric Pub
Total Pages: 472
Release: 1998
Genre: Medical
ISBN: 9780880488686

Download Psychiatric Side Effects of Prescription and Over-the-counter Medications Book in PDF, ePub and Kindle

Both prescription and non-prescription medications used in medicine and psychiatry can cause a varietyof problems for those taking them, both in terms of their behavior and their ability to think. The first book to thoroughly examine how to recognize and manage the psychological side-effects of these medicines, this exhaustive work also provides a fingertip source of vital information for everyone from psychiatrists, primary care doctors and other medical subspecialty practitioners to students, residents and general readers. Noted physicians Thomas Markham Brown and Alan Stoudemire cover all of the major medications used in medicine and psychiatry, with full chapters on such topics as: * Antipsychotics* Antidepressants* Lithium* Anticonvulsants* Anesthetic agents* Sedative-Hypnotic and related agents* Antibiotics* Cardiovascular agents* Antineoplastic agents* Gastrointestinal agents* Pulmonary agents* Hematologic agents* Antilipemic agents* Drugs affecting the endocrine system Throughout this information-packed reference, the authors, noted physicians Thomas Markham Brown and Alan Stoudemire, cover all of the major medications used in medicine and psychiatry. They focus on the fundamental ways drugs cause cognitive toxicity and map strategies for clinical management. They also address the consequences of drug interactions and the basic pathophysiology of central nervous system toxicity. With the help of Psychiatric Side Effects of Prescription and Over-the-Counter Medications, readers will be able to quickly identify the ways drugs sometimes negatively affect behavior and ability to reason, and then determine the best practical course for treating those problems. A CD-ROM containing the complete contents of Psychiatric Side Effects of Prescription and Over the Counter Medications is included. Fully searchable, this CD-ROM is compatible on both MACINTOSH and WINDOWS systems.


Consumer's Guide to Psychiatric Drugs

Consumer's Guide to Psychiatric Drugs
Author: John D. Preston
Publisher: Wellness Institute, Inc.
Total Pages: 368
Release: 2004-03
Genre: Family & Relationships
ISBN: 9781587411250

Download Consumer's Guide to Psychiatric Drugs Book in PDF, ePub and Kindle

This lay reference on psychiatric drugs outlines treatment options and tells patients what to expect. Illustrations.


Pharmacological Treatment of Mental Disorders in Primary Health Care

Pharmacological Treatment of Mental Disorders in Primary Health Care
Author: World Health Organization
Publisher: World Health Organization
Total Pages: 80
Release: 2009
Genre: Medical
ISBN: 9241547693

Download Pharmacological Treatment of Mental Disorders in Primary Health Care Book in PDF, ePub and Kindle

This manual attempts to provide simple, adequate and evidence-based information to health care professionals in primary health care especially in low- and middle-income countries to be able to provide pharmacological treatment to persons with mental disorders. The manual contains basic principles of prescribing followed by chapters on medicines used in psychotic disorders; depressive disorders; bipolar disorders; generalized anxiety and sleep disorders; obsessive compulsive disorders and panic attacks; and alcohol and opioid dependence. The annexes provide information on evidence retrieval, assessment and synthesis and the peer view process.


Deprescribing in Psychiatry

Deprescribing in Psychiatry
Author: Swapnil Gupta
Publisher: Oxford University Press, USA
Total Pages: 265
Release: 2019
Genre: Medical
ISBN: 0190654813

Download Deprescribing in Psychiatry Book in PDF, ePub and Kindle

Many people consider stopping their psychiatric medications, but prescribers may not know how to do this in a collaborative, systematic way. This book describes the ins and outs of how clinicians can work closely with their patients to consider whether or not to try decreasing medications. It outlines the how and when, and gives recommendations on what the prescriber and patient may encounter along the way.


Unhinged

Unhinged
Author: Daniel Carlat
Publisher: Simon and Schuster
Total Pages: 272
Release: 2010-05-18
Genre: Psychology
ISBN: 9781416596356

Download Unhinged Book in PDF, ePub and Kindle

IN THIS STIRRING AND BEAUTIFULLY WRITTEN WAKE-UP CALL, psychiatrist Daniel Carlat exposes deeply disturbing problems plaguing his profession, revealing the ways it has abandoned its essential purpose: to understand the mind, so that psychiatrists can heal mental illness and not just treat symptoms. As he did in his hard-hitting and widely read New York Times Magazine article "Dr. Drug Rep," and as he continues to do in his popular watchdog newsletter, The Carlat Psychiatry Report, he writes with bracing honesty about how psychiatry has so largely forsaken the practice of talk therapy for the seductive—and more lucrative—practice of simply prescribing drugs, with a host of deeply troubling consequences. Psychiatrists have settled for treating symptoms rather than causes, embracing the apparent medical rigor of DSM diagnoses and prescription in place of learning the more challenging craft of therapeutic counseling, gaining only limited understanding of their patients’ lives. Talk therapy takes time, whereas the fifteen-minute "med check" allows for more patients and more insurance company reimbursement. Yet DSM diagnoses, he shows, are premised on a good deal less science than we would think. Writing from an insider’s perspective, with refreshing forthrightness about his own daily struggles as a practitioner, Dr. Carlat shares a wealth of stories from his own practice and those of others that demonstrate the glaring shortcomings of the standard fifteen-minute patient visit. He also reveals the dangers of rampant diagnoses of bipolar disorder, ADHD, and other "popular" psychiatric disorders, and exposes the risks of the cocktails of medications so many patients are put on. Especially disturbing are the terrible consequences of overprescription of drugs to children of ever younger ages. Taking us on a tour of the world of pharmaceutical marketing, he also reveals the inner workings of collusion between psychiatrists and drug companies. Concluding with a road map for exactly how the profession should be reformed, Unhinged is vital reading for all those in treatment or considering it, as well as a stirring call to action for the large community of psychiatrists themselves. As physicians and drug companies continue to work together in disquieting and harmful ways, and as diagnoses—and misdiagnoses—of mental disorders skyrocket, it’s essential that Dr. Carlat’s bold call for reform is heeded.


Medications for Opioid Use Disorder Save Lives

Medications for Opioid Use Disorder Save Lives
Author: National Academies of Sciences, Engineering, and Medicine
Publisher: National Academies Press
Total Pages: 175
Release: 2019-06-16
Genre: Medical
ISBN: 0309486483

Download Medications for Opioid Use Disorder Save Lives Book in PDF, ePub and Kindle

The opioid crisis in the United States has come about because of excessive use of these drugs for both legal and illicit purposes and unprecedented levels of consequent opioid use disorder (OUD). More than 2 million people in the United States are estimated to have OUD, which is caused by prolonged use of prescription opioids, heroin, or other illicit opioids. OUD is a life-threatening condition associated with a 20-fold greater risk of early death due to overdose, infectious diseases, trauma, and suicide. Mortality related to OUD continues to escalate as this public health crisis gathers momentum across the country, with opioid overdoses killing more than 47,000 people in 2017 in the United States. Efforts to date have made no real headway in stemming this crisis, in large part because tools that already existâ€"like evidence-based medicationsâ€"are not being deployed to maximum impact. To support the dissemination of accurate patient-focused information about treatments for addiction, and to help provide scientific solutions to the current opioid crisis, this report studies the evidence base on medication assisted treatment (MAT) for OUD. It examines available evidence on the range of parameters and circumstances in which MAT can be effectively delivered and identifies additional research needed.


First Episode Psychosis

First Episode Psychosis
Author: Katherine J. Aitchison
Publisher: CRC Press
Total Pages: 152
Release: 2022-03-26
Genre: Medical
ISBN: 0429524145

Download First Episode Psychosis Book in PDF, ePub and Kindle

The new edition of this popular handbook has been thoroughly updated to include the latest data concerning treatment of first-episode patients. Drawing from their experience, the authors discuss the presentation and assessment of the first psychotic episode and review the appropriate use of antipsychotic agents and psychosocial approaches in effective management. This is an authoritative text written by a team of highly respected authors for psychiatrists, neurologists, primary care practitioners and health care professional working in psychiatry. Drawing from their experience, the presentation and assessment of the first psychotic episode are discussed, details regarding antipsychotic drugs and their appropriate use are reviewed and psychosocial approaches are examined. The resulting book offers a concise and valuable guide to those wishing to review the latest proposals for the treatment of first-episode psychosis supported by up-to-date references, in a single publication.


Assessment of Long-Term Health Effects of Antimalarial Drugs When Used for Prophylaxis

Assessment of Long-Term Health Effects of Antimalarial Drugs When Used for Prophylaxis
Author: National Academies of Sciences, Engineering, and Medicine
Publisher: National Academies Press
Total Pages: 427
Release: 2020-04-24
Genre: Medical
ISBN: 0309672104

Download Assessment of Long-Term Health Effects of Antimalarial Drugs When Used for Prophylaxis Book in PDF, ePub and Kindle

Among the many who serve in the United States Armed Forces and who are deployed to distant locations around the world, myriad health threats are encountered. In addition to those associated with the disruption of their home life and potential for combat, they may face distinctive disease threats that are specific to the locations to which they are deployed. U.S. forces have been deployed many times over the years to areas in which malaria is endemic, including in parts of Afghanistan and Iraq. Department of Defense (DoD) policy requires that antimalarial drugs be issued and regimens adhered to for deployments to malaria-endemic areas. Policies directing which should be used as first and as second-line agents have evolved over time based on new data regarding adverse events or precautions for specific underlying health conditions, areas of deployment, and other operational factors At the request of the Veterans Administration, Assessment of Long-Term Health Effects of Antimalarial Drugs When Used for Prophylaxis assesses the scientific evidence regarding the potential for long-term health effects resulting from the use of antimalarial drugs that were approved by FDA or used by U.S. service members for malaria prophylaxis, with a focus on mefloquine, tafenoquine, and other antimalarial drugs that have been used by DoD in the past 25 years. This report offers conclusions based on available evidence regarding associations of persistent or latent adverse events.


Novel Psychoactive Substances

Novel Psychoactive Substances
Author: Ornella Corazza
Publisher: Springer
Total Pages: 178
Release: 2017-08-09
Genre: Business & Economics
ISBN: 331960600X

Download Novel Psychoactive Substances Book in PDF, ePub and Kindle

In light of the recent emergence of Novel Psychoactive Substances (NPS) on a global scale, this book provides a timely analysis of the social and economic impact of the NPS phenomenon, and of the global policy and regulatory responses to it. It presents the first comprehensive overview of the international regulation, policy and market structure of the NPS phenomenon, offering a guide to inform legislative discussions and demonstrating from a comparative perspective the different approaches used to address the rise of NPS to date. It covers topics such as organized crime, drug markets, clinical evidence on NPS, and different regulatory approaches also in less explored settings such as prisons and sport environments. Overall, this highly informative and well-structured repository of different experiences with NPS policy, law and regulation offers an essential primary source of evidence for anyone interested in the area of drug and NPS policy, health economics and p ublic health.


Fluoxetine

Fluoxetine
Author: Graziano Pinna
Publisher:
Total Pages: 412
Release: 2015-04-01
Genre:
ISBN: 9781634820769

Download Fluoxetine Book in PDF, ePub and Kindle

Fluoxetine, best known by the trade name Prozac®, unlike other psychotropic drugs whose effects were serendipitously stumbled upon, was the first developed for a precise mechanism of action, that is, the ability to selectively inhibit serotonin reuptake, based upon the theory that increasing the availability of serotonin would treat major depression. Once approved by the FDA in 1987, fluoxetine quickly became the most prescribed psychotropic drug worldwide and its success in improving mood disorders has triggered the development of a large number of congener molecules, commonly known as SSRIs after their purported mechanism of action. However, a quarter of a century after its development, the idea that fluoxetine asserts its positive behavioral effect through inhibition of serotonergic reuptake is not firmly established. This book reviews several preclinical and clinical reports suggesting that the pharmacological effects of fluoxetine may be mediated by means other than the regulation of serotonin, including the regulation of gene expression, modifying epigenetic mechanisms as well as modifying microRNAs. One of the most prominent mechanisms for the therapeutic relevance of fluoxetine relates to influencing neuroplasticity by enhancing neurotropic factors, including BDNF signaling and altering adult neurogenesis. The ability of fluoxetine to rapidly increase neurosteroid levels accounts for the fast anxiolytic effects of this drug. Fluoxetine action at sigma-1 receptor or modulating glutamatergic neurotransmission as well as the combination of fluoxetine with other psychotropic drugs is discussed in relation to its therapeutic effects. While fluoxetine was primarily prescribed as an antidepressant, this drug currently represents a treatment of choice for a broad spectrum of psychiatric disorders, including post-traumatic stress disorder and a range of anxiety disorders. This drug even possesses analgesic actions and is a valuable therapy for stroke. This book also highlights emerging evidence on the gender-specific effects of fluoxetine, its potential adverse features, including its addiction liability in combination with psychostimulants, and the impact of perinatal fluoxetine exposure.